Dapi Website: Über die Autoren

Johanna Werning

Referentin für Statistik, Deutsches Arzneiprüfungsinstitut e. V. (DAPI), Berlin

Publikationen:

Innovative Arzneimittel bei Hepatitis C - Was kostet der Zusatznutzen?

Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study

Temporal synchrony between drug dispensings and adverse drug events? The example of statins & rhabdomyolysis and metamizole or clozapine & agranulocytosis

Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison

Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016

“Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription